Real-World Budget Impact of the Adoption of Insulin Glargine Biosimilars in Primary Care in England (2015-2018).

Diabetes Care
Ion AgirrezabalJuan M Cabasés

Abstract

Lantus, the reference insulin glargine used for the treatment of diabetes, lost its patent protection in 2014, opening the market to biosimilar competitors. First, to analyze the adoption rates of insulin glargine biosimilars in primary care in England and estimate the savings realized and missed, since an insulin glargine biosimilar was first used, and second, to assess potential variations in adoption rates across Clinical Commissioning Groups (CCGs). Data sets capturing information on all insulin glargine items prescribed by all general practitioners up to December 2018 were used. Total costs of insulin glargine and uptake rates of biosimilars were calculated. The real-world budget impact was estimated assuming the cost of reference insulin glargine for all items and comparing the total costs in this scenario with the total costs in the real world. The missed savings were estimated assuming the cost of biosimilars for all insulin glargine items. Choropleth maps were generated to assess potential variations in uptake across CCGs. Insulin glargine biosimilars generated savings of £900,000 between October 2015 (time of first prescription) and December 2018. The missed savings amounted to £25.6 million in this period, indicating...Continue Reading

References

Jun 6, 2014·BMJ : British Medical Journal·Ingrid Torjesen
Feb 25, 2018·Journal of Forensic and Legal Medicine·Paolo RoccoPaola Minghetti
Sep 25, 2018·Journal of Managed Care & Specialty Pharmacy·Johlee S OdinetGregory A Heindel
Oct 27, 2018·Nature Reviews. Rheumatology·Evrydiki KravvaritiPetros P Sfikakis
Nov 15, 2018·BMJ : British Medical Journal·Gareth Iacobucci
Oct 31, 2019·British Journal of Clinical Pharmacology·Katherine SaxbyReecha Sofat

❮ Previous
Next ❯

Citations

May 1, 2021·Pharmaceuticals·Manuel García-GoñiAlba Villacampa
Jun 2, 2021·Diabetes Technology & Therapeutics·Thomas DanneJan Bolinder
Dec 7, 2021·Frontiers in Public Health·Zejun LuoHao Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Lancet
Geremia B Bolli, D R Owens
Lancet
Lars G HemkensPeter T Sawicki
Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
Mercedes Rigla Cros
© 2022 Meta ULC. All rights reserved